What's breaking now, across thousands of outlets.
Milestone Pharmaceuticals is cutting costs and staff following the FDA approval of its heart arrhythmia treatment, with two top executives departing the leadership team. The company said in its third-quarter earnings ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
In July 2026 the committee voted 8-6 to expand access to six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500.
Plus, news about Merck KGaA, Rezolute, Vir, Orakl and Cellectis. Regeneron’s mid-stage POTS data: The biotech’s monoclonal antibody, baloncibart, given at 450 mg led to an average 11.4-beat-per-minute…
Liquid biopsies already help guide treatment, but researchers wanted to see if they can be used to diagnose people too.
Researchers have created a hybrid malaria parasite that combines the manufacturing advantages of the strain used in every current whole-parasite malaria vaccine with the much higher liver infectivity…
MARLBOROUGH, MA — Moderna is “on track and ready” to make thousands of doses of its Merck-partnered cancer vaccine as it prepares to file a marketing application by the end of this year with the FDA…
How many trips have you squeezed into the past 10 days? Whether you're in Boston or across the globe, in the Democratic Republic of the Congo, your daily routine keeps you on the move.
